| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.43 | 3e-20 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-19 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.32 | 7e-17 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.33 | 9e-17 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.3 | 3e-16 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.28 | 3e-16 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-15 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.34 | 6e-15 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.28 | 9e-15 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-14 |